Response to comment by P. Vassilakopoulos and colleagues

Ulrich Jaeger, Michael Praxmarer, Richard Greil, AGMT-NHL13 investigators, Ulrich Jaeger, Michael Praxmarer, Richard Greil, AGMT-NHL13 investigators

No abstract available

Keywords: aggressive B-cell lymphoma; first remission; randomized trial; rituximab maintenance.